A Prospective, 5-Week, Open Label, Randomized, Multi-Center, Parallel-Group Study Evaluating the Tolerability and Safety of Switching from Donepezil to an Initial Dose of 5 cm2 Rivastigmine Patch Formulation in Patients with Probable Alzheimer's disease
Description of Research
The purpose of this study is to examine the tolerability and safety of rivastigmine patch in patients who are being treated with donepezil (Aricept(r)). The study is being done to test two ways to switch patients from donepezil tablets to rivastigmine patch.
Study Number
HSR-06-0761
Inclusion/Notes
Between ages 50-85, with a diagnosis of dementia of Alzheimer's type
Additional screening criteria
